PubRank

Hans Förstl

Author PubWeight™ 81.92‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Selective changes of resting-state networks in individuals at risk for Alzheimer's disease. Proc Natl Acad Sci U S A 2007 5.16
2 Physical activity and incident cognitive impairment in elderly persons: the INVADE study. Arch Intern Med 2010 2.58
3 Lewy body and parkinsonian dementia: common, but often misdiagnosed conditions. Dtsch Arztebl Int 2010 2.27
4 Beta amyloid in Alzheimer's disease: increased deposition in brain is reflected in reduced concentration in cerebrospinal fluid. Biol Psychiatry 2009 1.85
5 Chronic kidney disease is associated with incident cognitive impairment in the elderly: the INVADE study. Nephrol Dial Transplant 2009 1.78
6 Cognitive impairment in 873 patients with idiopathic Parkinson's disease. Results from the German Study on Epidemiology of Parkinson's Disease with Dementia (GEPAD). J Neurol 2008 1.62
7 Mild cognitive impairment and dementia: the importance of modifiable risk factors. Dtsch Arztebl Int 2011 1.43
8 Neurodegeneration and the structure of time: clinical evidence for philosophical reasoning. Int Psychogeriatr 2008 1.38
9 Aberrant dependence of default mode/central executive network interactions on anterior insular salience network activity in schizophrenia. Schizophr Bull 2013 1.35
10 Clinical severity of Alzheimer's disease is associated with PIB uptake in PET. Neurobiol Aging 2008 1.31
11 High risk of cognitive and functional decline after postoperative delirium. A three-year prospective study. Dement Geriatr Cogn Disord 2008 1.30
12 Progression of cerebral amyloid load is associated with the apolipoprotein E ε4 genotype in Alzheimer's disease. Biol Psychiatry 2010 1.29
13 Frequency of dementia, depression, and other neuropsychiatric symptoms in 1,449 outpatients with Parkinson's disease. J Neurol 2010 1.24
14 Regional expansion of hypometabolism in Alzheimer's disease follows amyloid deposition with temporal delay. Biol Psychiatry 2011 1.22
15 White matter hyperintensities predict amyloid increase in Alzheimer's disease. Neurobiol Aging 2012 1.12
16 Chronic kidney disease and cognitive impairment: a systematic review and meta-analysis. Am J Nephrol 2012 1.12
17 Vitamin D deficiency, cognitive impairment and dementia: a systematic review and meta-analysis. Dement Geriatr Cogn Disord 2012 1.10
18 Heart rate variability and depression. Arch Gen Psychiatry 2006 1.09
19 Aberrant topology of striatum's connectivity is associated with the number of episodes in depression. Brain 2013 1.04
20 Increased intrinsic brain activity in the striatum reflects symptom dimensions in schizophrenia. Schizophr Bull 2012 1.02
21 A 6-month, open-label study of memantine in patients with frontotemporal dementia. Int J Geriatr Psychiatry 2008 1.02
22 Self-reported chemical sensitivity in Germany: a population-based survey. Int J Hyg Environ Health 2005 1.01
23 Insular Dysfunction Reflects Altered Between-Network Connectivity and Severity of Negative Symptoms in Schizophrenia during Psychotic Remission. Front Hum Neurosci 2013 1.00
24 Selectively and progressively disrupted structural connectivity of functional brain networks in Alzheimer's disease - revealed by a novel framework to analyze edge distributions of networks detecting disruptions with strong statistical evidence. Neuroimage 2013 0.98
25 The clock drawing test and questionable dementia: reliability and validity. Int J Geriatr Psychiatry 2002 0.95
26 Cerebral metabolic dysfunction in patients with dementia with Lewy bodies and visual hallucinations. Dement Geriatr Cogn Disord 2008 0.95
27 TNF polymorphisms in Alzheimer disease and functional implications on CSF beta-amyloid levels. Hum Mutat 2005 0.95
28 Disconnection of frontal and parietal areas contributes to impaired attention in very early Alzheimer's disease. J Alzheimers Dis 2011 0.94
29 Aberrant intrinsic connectivity of hippocampus and amygdala overlap in the fronto-insular and dorsomedial-prefrontal cortex in major depressive disorder. Front Hum Neurosci 2013 0.94
30 Activities of daily living, cerebral glucose metabolism, and cognitive reserve in Lewy body and Parkinson's disease. Dement Geriatr Cogn Disord 2008 0.91
31 Quality of life as an outcome in Alzheimer's disease and other dementias--obstacles and goals. BMC Neurol 2009 0.90
32 Weak independent association signals between IDE polymorphisms, Alzheimer's disease and cognitive measures. Neurobiol Aging 2006 0.90
33 Clinical and neurobiological correlates of soluble amyloid precursor proteins in the cerebrospinal fluid. Alzheimers Dement 2011 0.90
34 Urinary incontinence and its functional anatomy in frontotemporal lobar degenerations. Eur J Nucl Med Mol Imaging 2007 0.87
35 Surrogate decision making for patients with end-stage dementia. Int J Geriatr Psychiatry 2011 0.87
36 The usefulness of amyloid imaging in predicting the clinical outcome after two years in subjects with mild cognitive impairment. Curr Alzheimer Res 2013 0.87
37 Caregiver burden and needs in frontotemporal dementia. J Geriatr Psychiatry Neurol 2013 0.87
38 A functional polymorphism within plasminogen activator urokinase (PLAU) is associated with Alzheimer's disease. Hum Mol Genet 2006 0.87
39 Depressive symptoms and the risk of ischemic stroke in the elderly--influence of age and sex. PLoS One 2012 0.86
40 Prediction of Alzheimer's disease using individual structural connectivity networks. Neurobiol Aging 2012 0.85
41 [Incidence and risk factors of delirium after hip surgery]. Psychiatr Prax 2004 0.85
42 Metabolic and endocrine factors in mild cognitive impairment. Ageing Res Rev 2010 0.85
43 Drug profile: transdermal rivastigmine patch in the treatment of Alzheimer disease. CNS Neurosci Ther 2010 0.85
44 Shifted intrinsic connectivity of central executive and salience network in borderline personality disorder. Front Hum Neurosci 2013 0.84
45 Quantitative longitudinal interrelationships between brain metabolism and amyloid deposition during a 2-year follow-up in patients with early Alzheimer's disease. Eur J Nucl Med Mol Imaging 2012 0.84
46 Association of the tau haplotype H2 with age at onset and functional alterations of glucose utilization in frontotemporal dementia. Am J Psychiatry 2007 0.84
47 Staged decline of visual processing capacity in mild cognitive impairment and Alzheimer's disease. Neurobiol Aging 2009 0.83
48 Survival in a German population with frontotemporal lobar degeneration. Neuroepidemiology 2011 0.83
49 Reduction of Long-Term Care Dependence After an 8-Year Primary Care Prevention Program for Stroke and Dementia: The INVADE Trial. J Am Heart Assoc 2012 0.83
50 Fluoro-deoxy-glucose positron emission tomography correlates of impaired activities of daily living in dementia with Lewy bodies: implications for cognitive reserve. Am J Geriatr Psychiatry 2009 0.83
51 The cathepsin D rs17571 polymorphism: effects on CSF tau concentrations in Alzheimer disease. Hum Mutat 2006 0.82
52 Age-related cerebral perfusion changes in the parietal and temporal lobes measured by pulsed arterial spin labeling. J Magn Reson Imaging 2011 0.81
53 [Alzheimer's disease: knowledge and attitudes in a representative survey]. Neuropsychiatr 2008 0.81
54 New aspects of psychiatric morbidity in idiopathic environmental intolerances. J Occup Environ Med 2006 0.81
55 Accelerated clinical decline in well-educated patients with frontotemporal lobar degenerations. Eur Arch Psychiatry Clin Neurosci 2009 0.80
56 Cognitive decline in the behavioral variant of frontotemporal dementia. Int Psychogeriatr 2010 0.80
57 Personality change in old age. Curr Opin Psychiatry 2007 0.79
58 Asymmetric loss of parietal activity causes spatial bias in prodromal and mild Alzheimer's disease. Biol Psychiatry 2011 0.79
59 Right prefrontal hypometabolism predicts delusions in dementia with Lewy bodies. Neurobiol Aging 2008 0.79
60 Agitation in the morning: symptom of depression in dementia? Int J Geriatr Psychiatry 2009 0.79
61 Male gender is associated with greater cerebral hypometabolism in frontotemporal dementia: evidence for sex-related cognitive reserve. Int J Geriatr Psychiatry 2007 0.79
62 Importance of circadian rhythmicity in the cholinergic treatment of Alzheimer's disease: focus on galantamine*. Curr Med Res Opin 2008 0.78
63 Double-blind placebo-controlled provocation study in patients with subjective Multiple Chemical Sensitivity (MCS) and matched control subjects. Clin Toxicol (Phila) 2008 0.78
64 No association of chromatin-modifying protein 2B with sporadic frontotemporal dementia. Neurobiol Aging 2006 0.78
65 Psychiatric morbidity and toxic burden in patients with environmental illness: a controlled study. Psychosom Med 2006 0.78
66 Patterns of cognitive performance in Subcortical Ischemic Vascular Disease (SIVD). J Neuropsychiatry Clin Neurosci 2014 0.77
67 [Screening of cognitive functions and the prediction of incident dementia by means of the SIDAM]. Psychiatr Prax 2007 0.77
68 Variability of cognitive performance during hemodialysis: standardization of cognitive assessment. Dement Geriatr Cogn Disord 2014 0.77
69 Predicting effective connectivity from resting-state networks in healthy elderly and patients with prodromal Alzheimer's disease. Hum Brain Mapp 2013 0.77
70 Clock drawing test: is it useful for dementia screening in patients having Parkinson disease with and without depression? J Geriatr Psychiatry Neurol 2013 0.76
71 Dementia in the Greco-Roman world. J Neurol Sci 2006 0.76
72 Brain metabolic correlates of cerebrospinal fluid beta-amyloid 42 and tau in Alzheimer's disease. Dement Geriatr Cogn Disord 2009 0.76
73 Association between the presenilin-1 mutation Glu318Gly and complaints of memory impairment. Neurobiol Aging 2001 0.76
74 [Increased level of tonic sympathetic arousal in high-vs. low-alexithymic cervical dystonia patients]. Psychother Psychosom Med Psychol 2002 0.76
75 Cerebrospinal fluid BACE1 activity and brain amyloid load in Alzheimer's disease. ScientificWorldJournal 2012 0.75
76 The will to live instead of euthanasia: neurodegenerative diseases as seen by the sufferers themselves. Dtsch Arztebl Int 2008 0.75
77 Additive scales in degenerative disease--calculation of effect sizes and clinical judgment. BMC Med Res Methodol 2011 0.75
78 Cholinesterase inhibitor treatment in patients with delirium. Lancet 2011 0.75
79 Gaps Between Aims and Achievements in Therapeutic Modification of Neuronal Damage ("Neuroprotection"). Neurotherapeutics 2015 0.75
80 Why is it so difficult to evaluate nursing interventions in dementia? Dement Geriatr Cogn Dis Extra 2012 0.75
81 Intrinsic brain activity of cognitively normal older persons resembles more that of patients both with and at risk for Alzheimer's disease than that of healthy younger persons. Brain Connect 2014 0.75
82 Suitability of the 6CIT as a screening test for dementia in primary care patients. Aging Ment Health 2013 0.75
83 Senile anorexia: three cases with complicated treatment and two occurrences of a Pisa syndrome. Int J Geriatr Psychiatry 2012 0.75
84 Health care utilization in frontotemporal lobar degeneration. Alzheimer Dis Assoc Disord 2012 0.75
85 [Trichoma (Plica polonica) - a contemporary case with a historical disease]. Neuropsychiatr 2008 0.75
86 Alzheimer-plus. Int Psychogeriatr 2003 0.75
87 Neuropsychological and positron emission tomography correlates in idiopathic environmental intolerances. Scand J Work Environ Health 2007 0.75
88 Metabolic alterations associated with impaired clock drawing in Lewy body dementia. Psychiatry Res 2010 0.75
89 [Schizophrenic psychosis with polycystic ovarian syndrome and lupus erythematosus]. Neuropsychiatr 2011 0.75
90 [The cardiovascular risk of schizophrenic patients]. Neuropsychiatr 2007 0.75
91 [Von Economo neurons and insular cortex - the bridge between soma and psyche]. Neuropsychiatr 2010 0.75